| dc.contributor.author | Samiksha Dewangan, 18021020161) | |
| dc.date.accessioned | 2022-08-02T05:12:20Z | |
| dc.date.available | 2022-08-02T05:12:20Z | |
| dc.date.issued | 2022-05 | |
| dc.identifier.uri | http://10.10.11.6/handle/1/9994 | |
| dc.description.abstract | Research in a developing field of medicine known as Integrative oncology research is
seeking to determine whether complementary therapies, including herbal medications, are
safe and beneficial when used in conjunction with traditional cancer treatments. HIF-1
(Hypoxia-Inducible Factor 1) acts as transcriptional activator which intervenes versatile
reactions to hypoxic condition | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | GALGOTIAS UNIVERSITY | en_US |
| dc.subject | Hypoxia, Hypoxia inducible factor, malignant growth, Gene articulation, Reactive oxygen species (ROS), Mitogen-activated protein kinase (MAPK), Angiotensin. | en_US |
| dc.title | HYPOXIA INDUCIBLE FACTOR (HIF): A POTENTIAL MOLECULAR TARGET FOR HERBAL MEDICINE TO TREAT CANCER | en_US |
| dc.type | Other | en_US |
